Lb Pharmaceuticals Inc · NASDAQ:LBRX
Deep Track Capital, LP reported a 11.70% stake in Lb Pharmaceuticals Inc (Schedule 13D/A)
Event Feb 6, 2025 · Filed Feb 10, 2026
Deep Track Capital, LP reported a 11.70% stake in Lb Pharmaceuticals Inc, 3,352,804 shares, with active intent on Feb 6, 2025. Filed Feb 10, 2026 (Schedule 13D/A).
- Stake
- 11.70%
- Shares
- 3,352,804
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 9.40% | 2,686,138 |
| Deep Track Special Opportunities Fund, LP | 2.30% | 666,666 |
| Deep Track Capital, LP | 11.70% | 3,352,804 |
| David Kroin | 11.70% | 3,352,804 |
Source
Related
- Lb Pharmaceuticals Inc
- Deep Track Capital, LP
- Lb Pharmaceuticals Inc shareholders
- Schedule 13D · Deep Track Capital, LP · Sep 19, 2025
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026